Defining and conceptualising the commercial determinants of health

Article indépendant

GILMORE, Anna B. | FABBRI, Alice | BAUM, Fran | BERTSCHER, Adam | BONDY, Krista | CHANG, Ha-Joon | DEMAIO, Sandro | ERZSE, Agnes | FREUDENBERG, Nicholas | FRIEL, Sharon | HOFMAN, Karen J. | JOHNS, Paula | KARIM, Safura Abdool | LACY-NICHOLS, Jennifer | MARANHA PAES DE CARVALHO, Camila | MARTEN, Robert | MCKEE, Martin | PETTICREW, Mark | ROBERTSON, Lindsay | TANGCHAROENSATHIEN, Viroj | THOW, Anne Marie

Although commercial entities can contribute positively to health and society there is growing evidence that the products and practices of some commercial actors—notably the largest transnational corporations—are responsible for escalating rates of avoidable ill health, planetary damage, and social and health inequity; these problems are increasingly referred to as the commercial determinants of health. The climate emergency, the non-communicable disease epidemic, and that just four industry sectors (ie, tobacco, ultra-processed food, fossil fuel, and alcohol) already account for at least a third of global deaths illustrate the scale and huge economic cost of the problem. This paper, the first in a Series on the commercial determinants of health, explains how the shift towards market fundamentalism and increasingly powerful transnational corporations has created a pathological system in which commercial actors are increasingly enabled to cause harm and externalise the costs of doing so. Consequently, as harms to human and planetary health increase, commercial sector wealth and power increase, whereas the countervailing forces having to meet these costs (notably individuals, governments, and civil society organisations) become correspondingly impoverished and disempowered or captured by commercial interests. This power imbalance leads to policy inertia; although many policy solutions are available, they are not being implemented. Health harms are escalating, leaving health-care systems increasingly unable to cope. Governments can and must act to improve, rather than continue to threaten, the wellbeing of future generations, development, and economic growth.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00013-2/fulltext

Voir la revue «The Lancet, 401»

Autres numéros de la revue «The Lancet»

Consulter en ligne

Suggestions

Du même auteur

Defining and conceptualising the commercial d...

Article indépendant | GILMORE, Anna B. | The Lancet | n°10383 | vol.401

Although commercial entities can contribute positively to health and society there is growing evidence that the products and practices of some commercial actors—notably the largest transnational corporations—are responsible for es...

Changing life expectancy in European countrie...

Article | STEEL, Nicholas | The Lancet public health

Background: Decades of steady improvements in life expectancy in Europe slowed down from around 2011, well before the COVID-19 pandemic, for reasons which remain disputed. We aimed to assess how changes in risk factors and cause-s...

Changing life expectancy in European countrie...

Article indépendant | STEEL, Nicholas | The Lancet public health

Background: Decades of steady improvements in life expectancy in Europe slowed down from around 2011, well before the COVID-19 pandemic, for reasons which remain disputed. We aimed to assess how changes in risk factors and cause-s...

De la même série

Defining and conceptualising the commercial d...

Article indépendant | GILMORE, Anna B. | The Lancet | n°10383 | vol.401

Although commercial entities can contribute positively to health and society there is growing evidence that the products and practices of some commercial actors—notably the largest transnational corporations—are respon...

Redefining vulnerability in the era of Covid-...

Article indépendant | The Lancet | n°10230 | vol.395

What does it mean to be vulnerable? Vulnerable groups of people are those that are disproportionally exposed to risk, but who is included in these groups can change dynamically. A person not considered vulnerable at the outset of ...

What does it mean to be made vulnerable in th...

Article indépendant | AHMAD, Ayesha | The Lancet | n°10235 | vol.395

We read with interest the Editorial about redefining vulnerability in the era of coronavirus disease 2019 (COVID-19). The Editors recognise underserved and marginalised populations enduring the COVID-19 pandemic, and that the cate...

Felicia Marie Knaul : advocate for better pai...

Article indépendant | DAVIES, Rachael | The Lancet | n°10128 | vol.391

The time before her father died of stomach cancer in 1984 had a lasting impact on Felicia Knaul. “Each day brought new and ever-more challenging horrors—bone metastases popping up throughout his body…lungs filli...

Early palliative care for patients with advan...

Article indépendant | ZIMMERMANN, Camilla | The Lancet | n°9930 | vol.383

Background: Patients with advanced cancer have reduced quality of life, which tends to worsen towards the end of life. We assessed the effect of early palliative care in patients with advanced cancer on several aspects of quality ...

Chargement des enrichissements...